6-(1-Piperazinyl)-quinoxaline, process for its preparation and pharmaceutical compositions thereof
申请人:Merck & Co., Inc.
公开号:EP0000121A1
公开(公告)日:1979-01-10
6-(1-Piperazinyl) quinoxaline and pharmaceutically acceptable salts thereof have serotoninmimetic activity. It is prepared by reducing the nitro group of 1-(3-amino-4- nitrophenyl) piperazine followed by treatment with glyoxal.
6-(1-
哌嗪基)
喹喔啉及其药学上可接受的盐类具有拟
血清素活性。 其制备方法是还原 1-(3-
氨基-4-
硝基苯基)
哌嗪的硝基,然后用
乙二醛处理。